We are live on ! Find out more
ECP

Empyrean Capital Partners Portfolio holdings

AUM $3.03B
1-Year Est. Return 47.81%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+47.81%
3 Year Est. Return
+131.37%
5 Year Est. Return
+161.39%
10 Year Est. Return
+590.42%
AUM
$2.84B
AUM Growth
+$220M
Cap. Flow
+$232M
Cap. Flow %
8.16%
Top 10 Hldgs %
60.03%
Holding
67
New
27
Increased
4
Reduced
9
Closed
14

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$47.1M
2
DOV icon
Dover
DOV
+$36.2M
3
VOD icon
Vodafone
VOD
+$32.8M
4
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$28.1M
5
B
Barrick Mining
B
+$17.8M

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.89%
2 Healthcare 12.59%
3 Energy 8.63%
4 Communication Services 5.31%
5 Materials 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOD icon
51
Vodafone
VOD
$40.9B
-892,268
Closed -$32.8M
VZ icon
52
Verizon
VZ
$214B
-4,851
Closed -$231K
XLV icon
53
State Street Health Care Select Sector SPDR ETF
XLV
$43.5B
-189,000
Closed -$11.1M
XLV icon
54
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.5B
-4,000,000
Closed -$234M
DISCK
55
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
-729,196
Closed -$28.1M
NGHC
56
DELISTED
National General Holdings Corp
NGHC
-955,000
Closed -$13.4M
HAWK
57
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
-125,000
Closed -$3.05M

Similar funds

Empyrean Capital Partners's Q2 2014 Portfolio in Review

As of Q2 2014, Empyrean Capital Partners held 67 positions worth $2.84B, up 8.4% from $2.62B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Empyrean Capital Partners deployed $232M of net new capital in Q2 2014, opening 27 new positions and adding to 4 existing holdings. Its largest new stake was Allergan Inc: 500,000 shares worth $84.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 71% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Liberty Media Series A, an estimated $10.3M trimmed.

  • Empyrean Capital Partners's largest Q2 2014 buy was Allergan Inc: 500,000 shares worth $84.6M.
  • Empyrean Capital Partners added most to UnitedHealth in Q2 2014, an estimated $46M increase.
  • Empyrean Capital Partners's biggest Q2 2014 reduction was Liberty Media Series A, cutting an estimated $10.3M.
  • Empyrean Capital Partners fully exited Visa in Q2 2014, selling an estimated $47.1M.
  • Empyrean Capital Partners's ten largest holdings make up 60% of its $2.84B portfolio in Q2 2014.
  • Empyrean Capital Partners opened 27 new positions and closed 14 in Q2 2014.
  • Empyrean Capital Partners's portfolio value rose 8.4% quarter-over-quarter to $2.84B.

Based on Empyrean Capital Partners's 13F filing for Q2 2014, filed 14 Aug 2014.